TY - JOUR
T1 - An enhanced recovery after surgery pathway in pediatric colorectal surgery improves patient outcomes
AU - Purcell, Laura N.
AU - Marulanda, Kathleen
AU - Egberg, Matthew
AU - Mangat, Sabrina
AU - McCauley, Christopher
AU - Chaumont, Nicole
AU - Sadiq, Timothy S.
AU - Lupa, Concetta
AU - McNaull, Peggy
AU - McLean, Sean E.
AU - Hayes-Jordan, Andrea
AU - Phillips, Michael R.
N1 - Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2021/1
Y1 - 2021/1
N2 - Introduction: Enhanced recovery after surgery (ERAS) pathways in adult colorectal surgery are known to reduce complications, readmissions, and length of stay (LOS). However, there is a paucity of ERAS data for pediatric colorectal surgery. Methods: A 2014–2018 single-institution, retrospective cohort study was performed on pediatric colorectal surgery patients (2–18 years) pre- and post-ERAS pathway implementation. Bivariate analysis and linear regression were used to determine if ERAS pathway implementation reduced total morphine milligram equivalents per kilogram (MME/kg), LOS, and time to oral intake. Results: 98 (70.5%) and 41 (29.5%) patients were managed with ERAS and non-ERAS pathways, respectively. There was no statistical difference in age, sex, diagnosis, or use of laparoscopic technique between cohorts. The ERAS cohort experienced a significant reduction in total MME/kg, Foley duration, time to oral intake, and LOS with no increase in complications. The presence of an ERAS pathway reduced the total MME/kg (− 0.071, 95% CI − 0.10, − 0.043) when controlling for covariates. Conclusion: The use of an ERAS pathway reduces opioid utilization, which is associated with a reduction in LOS and expedites the initiation of oral intake, in colorectal pediatric surgery patients. Pediatric ERAS pathways should be incorporated into the care of pediatric patients undergoing colorectal surgery. Level of evidence: Level III evidence. Type of study: Retrospective cohort study.
AB - Introduction: Enhanced recovery after surgery (ERAS) pathways in adult colorectal surgery are known to reduce complications, readmissions, and length of stay (LOS). However, there is a paucity of ERAS data for pediatric colorectal surgery. Methods: A 2014–2018 single-institution, retrospective cohort study was performed on pediatric colorectal surgery patients (2–18 years) pre- and post-ERAS pathway implementation. Bivariate analysis and linear regression were used to determine if ERAS pathway implementation reduced total morphine milligram equivalents per kilogram (MME/kg), LOS, and time to oral intake. Results: 98 (70.5%) and 41 (29.5%) patients were managed with ERAS and non-ERAS pathways, respectively. There was no statistical difference in age, sex, diagnosis, or use of laparoscopic technique between cohorts. The ERAS cohort experienced a significant reduction in total MME/kg, Foley duration, time to oral intake, and LOS with no increase in complications. The presence of an ERAS pathway reduced the total MME/kg (− 0.071, 95% CI − 0.10, − 0.043) when controlling for covariates. Conclusion: The use of an ERAS pathway reduces opioid utilization, which is associated with a reduction in LOS and expedites the initiation of oral intake, in colorectal pediatric surgery patients. Pediatric ERAS pathways should be incorporated into the care of pediatric patients undergoing colorectal surgery. Level of evidence: Level III evidence. Type of study: Retrospective cohort study.
UR - https://www.scopus.com/pages/publications/85094858043
UR - https://www.scopus.com/pages/publications/85094858043#tab=citedBy
U2 - 10.1016/j.jpedsurg.2020.09.028
DO - 10.1016/j.jpedsurg.2020.09.028
M3 - Article
C2 - 33131774
AN - SCOPUS:85094858043
SN - 0022-3468
VL - 56
SP - 115
EP - 120
JO - Journal of pediatric surgery
JF - Journal of pediatric surgery
IS - 1
ER -